Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides

被引:174
作者
Simoes, S
Slepushkin, V
Gaspar, R
de Lima, MCP
Duzgunes, N
机构
[1] Univ Pacific, Sch Dent, Dept Microbiol, San Francisco, CA 94115 USA
[2] Univ Coimbra, Dept Biochem, P-3000 Coimbra, Portugal
[3] Univ Coimbra, Ctr Neurosci, P-3000 Coimbra, Portugal
[4] Univ Coimbra, Fac Pharm, Pharmaceut Technol Lab, P-3000 Coimbra, Portugal
关键词
gene delivery; cationic liposomes; transferrin; fusigenic peptides;
D O I
10.1038/sj.gt.3300674
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Potential problems with the use of viral vectors for gene therapy necessitate the development of efficient nonviral vectors. The association of transferrin, or the PH-sensitive peptide GALA, with cationic liposomes composed of 1,2-dioleoyl-3-(trimethylammonium) propane and its equimolar mixture with dioleoylphosphatidylethanolamine, under conditions where the lipsosome/DNA complex is negatively charged, drastically increased luciferase expression from pCMVluc. The percentage of cells transfected, measured by beta-galactosidase expression, was also increased by about 10-fold. The zeta potential of the ternary complexes was lower than that of the liposome/DNA complexes. Transfection activity of positively charged complexes was also enhanced by association with transferrin, GALA lot the influenza hemagglutinin N terminal peptide HA-2, but to a smaller extent compared with the negatively charged complexes. The enhancement of gene delivery by transferrin or GALA was not affected significantly by the presence of serum and did not cause significant cytotoxicity. Our results indicate that negatively charged ternary complexes of cationic liposomes, DNA and transferrin, or fusigenic peptides, can facilitate efficient transfection of cultured cells, and that they may alleviate the drawbacks of the use of highly positively charged complexes for gene delivery in vivo.
引用
收藏
页码:955 / 964
页数:10
相关论文
共 62 条
[1]  
ANDERSON WF, 1995, SCI AM, V273, P124
[2]   GENE-THERAPY - A NOVEL FORM OF DRUG-DELIVERY [J].
BLAU, HM ;
SPRINGER, ML .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (18) :1204-1207
[3]   BAFILOMYCINS - A CLASS OF INHIBITORS OF MEMBRANE ATPASES FROM MICROORGANISMS, ANIMAL-CELLS, AND PLANT-CELLS [J].
BOWMAN, EJ ;
SIEBERS, A ;
ALTENDORF, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (21) :7972-7976
[4]   Receptor ligand-facilitated gene transfer: Enhancement of liposome-mediated gene transfer and expression by transferrin [J].
Cheng, PW .
HUMAN GENE THERAPY, 1996, 7 (03) :275-282
[5]  
Ciccarone V., 1993, FOCUS, V15, P80
[6]  
COTTEN M, 1993, METHOD ENZYMOL, V217, P618
[7]   TRANSFER OF GENES TO HUMANS - EARLY LESSONS AND OBSTACLES TO SUCCESS [J].
CRYSTAL, RG .
SCIENCE, 1995, 270 (5235) :404-410
[8]   STUDIES ON THE MECHANISM OF MEMBRANE-FUSION - ROLE OF HEADGROUP COMPOSITION IN CALCIUM-INDUCED AND MAGNESIUM-INDUCED FUSION OF MIXED PHOSPHOLIPID-VESICLES [J].
DUZGUNES, N ;
WILSCHUT, J ;
FRALEY, R ;
PAPAHADJOPOULOS, D .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 642 (01) :182-195
[9]   MEMBRANE DESTABILIZATION BY N-TERMINAL PEPTIDES OF VIRAL ENVELOPE PROTEINS [J].
DUZGUNES, N ;
SHAVNIN, SA .
JOURNAL OF MEMBRANE BIOLOGY, 1992, 128 (01) :71-80
[10]  
DUZGUNES N, 1997, C ART SELF SYST GEN